Saturday, 10 October 2026 Updated 1 hour ago
The News Engine
Latest
Health Australia

Women with PMOS should get subsidised weight-loss drugs, Australian advocates say

The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for GLP-1 drugs to be approved on the Pharmaceutical Benefits…

Image accompanying the story: Women with PMOS should get subsidised weight-loss drugs, Australian advocates say
Image: Photograph: James Manning/PA · via The Guardian

The Guardian reports that the Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for GLP-1 drugs to be approved on the Pharmaceutical Benefits Scheme for people living with the condition.

This health story centres on Australia. Names and organisations mentioned in the coverage include PMOS, Australian and GLP-.

Why it matters

Health stories are worth following because they can shape treatment options, guidance and how services are delivered. Readers should rely on medical professionals for personal advice.

Key details

Location
Australia · Oceania
Reported by
The Guardian
First reported
Key names
PMOS, Australian, GLP-, TGA
Section
Health

Sources

This is an independent summary. Read the full, original reporting from the publisher:

Read the full story at The Guardian

Spotted an error? Request a correction · How this summary was produced

Related Stories